Reversible biotinylated oligosaccharides: a new approach for a better management of anticoagulant therapy

Pierre Savi(Sanofi (France)), Jean‐Marc Herbert(Sanofi (France)), L. Millet(Sanofi (France)), Paul Schaeffer(Universidad La Salle), Philippe Duchaussoy(Sanofi (France)), Françoise Bono(OSE Immunotherapeutics (France)), J P Hérault(Sanofi (France)), Maurice Petitou(Sanofi (France))
Journal of Thrombosis and Haemostasis
July 19, 2008
Cited by 64


Related Papers